Professor Onn Min Kon is a Respiratory Physician and the Lead Clinician for the TB service at Imperial College Healthcare NHS Trust. He runs a busy TB service at St Mary’s Hospital which is a tertiary centre for MDR-TB and a regional centre for endobronchial ultrasound. He is also Lead Clinician for the North West London TB sector.
He is the chair of the British Thoracic Society Joint Tuberculosis Committee and ex-chair of the British Thoracic Society Specialist Advisory Committee. He is also a member of the National MDRTB advisory service. He has served on the Department of Health Find and Treat Steering Committee. He has interests in the clinical and immuno-diagnosis of TB, the delivery of care and management of TB.
Professor Kon obtained his undergraduate degree in Medicine at University College and Middlesex Hospital School of Medicine before training in respiratory medicine at the Royal Brompton, St Mary's and Charing Cross hospitals. He performed research on immunosuppressants in asthma under the supervision of Professor Barry Kay and Professor Neil Barnes at the Royal Brompton Hospital and London Chest Hospital.
He is a principal investigator in the Centre for Respiratory Infection at Imperial College London and is also co-lead investigator with Professor Ajit Lalvani for the ‘IDEA’ study - the largest multicentre study evaluating the role of interferon gamma release assays in active TB funded by the National Institute for Health Research.
Professor Kon organises and runs on behalf of the NIHR HPRU for Respiratory Infections and Public Health England, the London Advanced TB course which is an annual intensive clinical TB course designed to update clinicians in all aspects of TB care.
He is also involved in studies evaluating the immunology and novel therapies in airway disease and based at the Imperial Clinical Respiratory Research Unit at St Mary’s Hospital. He has close academic ties with Professor Sebastian Johnston, Professor Peter Openshaw and Dr Trevor Hansel at St Mary’s Hospital. Along with Dr Hansel, he has helped develop non-invasive sampling techniques in the airway.
He has over 100 peer reviewed publications in tuberculosis and airway disease and is a regular lecturer for Imperial College London.
et al., Evaluation of serum inflammatory biomarkers as predictors of treatment outcome in pulmonary tuberculosis, International Journal of Tuberculosis and Lung Disease, ISSN:1815-7920
et al., 2017, Drug-induced liver injury from antituberculous treatment: a retrospective study from a large TB centre in the UK, Bmc Infectious Diseases, Vol:17, ISSN:1471-2334
et al., 2017, Evaluation of prediagnosis emergency department presentations in patients with active tuberculosis: the role of chest radiography, risk factors and symptoms., Bmj Open Respir Res, Vol:4, ISSN:2052-4439
et al., 2017, Drug resistant TB: UK multicentre study (DRUMS): Treatment, management and outcomes in London and West Midlands 2008-2014, Journal of Infection, Vol:74, ISSN:0163-4453, Pages:260-271
et al., 2017, The adverse effects and choice of injectable agents in MDR-TB: amikacin or capreomycin., Antimicrob Agents Chemother